207 related articles for article (PubMed ID: 34758724)
21. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma.
Li SS; Jiang WL; Xiao WQ; Li K; Zhang YF; Guo XY; Dai YQ; Zhao QY; Jiang MJ; Lu ZJ; Wan R
World J Gastrointest Oncol; 2019 Aug; 11(8):599-621. PubMed ID: 31435462
[TBL] [Abstract][Full Text] [Related]
22. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.
Patel A; Dharmarajan V; Vought VE; Cosgrove MS
J Biol Chem; 2009 Sep; 284(36):24242-56. PubMed ID: 19556245
[TBL] [Abstract][Full Text] [Related]
23. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
Li M; Shi M; Xu Y; Qiu J; Lv Q
Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
[TBL] [Abstract][Full Text] [Related]
24. Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation.
Patel A; Vought VE; Swatkoski S; Viggiano S; Howard B; Dharmarajan V; Monteith KE; Kupakuwana G; Namitz KE; Shinsky SA; Cotter RJ; Cosgrove MS
J Biol Chem; 2014 Jan; 289(2):868-84. PubMed ID: 24235145
[TBL] [Abstract][Full Text] [Related]
25. Histone methyltransferase KMT2D inhibits ENKTL carcinogenesis by epigenetically activating SGK1 and SOCS1.
Zhang YH; Tao Q; Zhang WY; Zhao S; Liu WP; Gao LM
Genes Genomics; 2024 Feb; 46(2):203-212. PubMed ID: 37523130
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem and progenitor cell proliferation and differentiation requires the trithorax protein Ash2l.
Lüscher-Firzlaff J; Chatain N; Kuo CC; Braunschweig T; Bochyńska A; Ullius A; Denecke B; Costa IG; Koschmieder S; Lüscher B
Sci Rep; 2019 Jun; 9(1):8262. PubMed ID: 31164666
[TBL] [Abstract][Full Text] [Related]
27. DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.
Skvortsova K; Masle-Farquhar E; Luu PL; Song JZ; Qu W; Zotenko E; Gould CM; Du Q; Peters TJ; Colino-Sanguino Y; Pidsley R; Nair SS; Khoury A; Smith GC; Miosge LA; Reed JH; Kench JG; Rubin MA; Horvath L; Bogdanovic O; Lim SM; Polo JM; Goodnow CC; Stirzaker C; Clark SJ
Cancer Cell; 2019 Feb; 35(2):297-314.e8. PubMed ID: 30753827
[TBL] [Abstract][Full Text] [Related]
28. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L.
Liu W; Hu D; Li J; Xu Q; Chen Z; Xu B
Cancer Biol Ther; 2023 Dec; 24(1):2216041. PubMed ID: 37287122
[TBL] [Abstract][Full Text] [Related]
29. Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.
Rickels R; Herz HM; Sze CC; Cao K; Morgan MA; Collings CK; Gause M; Takahashi YH; Wang L; Rendleman EJ; Marshall SA; Krueger A; Bartom ET; Piunti A; Smith ER; Abshiru NA; Kelleher NL; Dorsett D; Shilatifard A
Nat Genet; 2017 Nov; 49(11):1647-1653. PubMed ID: 28967912
[TBL] [Abstract][Full Text] [Related]
30. Targeting liquid-liquid phase separation in pancreatic cancer.
Ming Y; Chen X; Xu Y; Wu Y; Wang C; Zhang T; Mao R; Fan Y
Transl Cancer Res; 2019 Feb; 8(1):96-103. PubMed ID: 35116738
[TBL] [Abstract][Full Text] [Related]
31. Small molecule inhibitors of the prostate cancer target KMT2D.
Yu Q; Liao Z; Liu D; Xie W; Liu Z; Liao G; Wang C
Biochem Biophys Res Commun; 2020 Dec; 533(3):540-547. PubMed ID: 32988590
[TBL] [Abstract][Full Text] [Related]
32. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
[TBL] [Abstract][Full Text] [Related]
33. Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration.
Pacelli C; Adipietro I; Malerba N; Squeo GM; Piccoli C; Amoresano A; Pinto G; Pucci P; Lee JE; Ge K; Capitanio N; Merla G
Cells; 2020 Jul; 9(7):. PubMed ID: 32668765
[No Abstract] [Full Text] [Related]
34. H2B ubiquitylation enhances H3K4 methylation activities of human KMT2 family complexes.
Kwon M; Park K; Hyun K; Lee JH; Zhou L; Cho YW; Ge K; Skalnik DG; Muir TW; Kim J
Nucleic Acids Res; 2020 Jun; 48(10):5442-5456. PubMed ID: 32365172
[TBL] [Abstract][Full Text] [Related]
35. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.
Zhang J; Dominguez-Sola D; Hussein S; Lee JE; Holmes AB; Bansal M; Vlasevska S; Mo T; Tang H; Basso K; Ge K; Dalla-Favera R; Pasqualucci L
Nat Med; 2015 Oct; 21(10):1190-8. PubMed ID: 26366712
[TBL] [Abstract][Full Text] [Related]
36. Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex.
Shinsky SA; Cosgrove MS
J Biol Chem; 2015 Oct; 290(43):25819-33. PubMed ID: 26324722
[TBL] [Abstract][Full Text] [Related]
37. A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.
Cheng J; Blum R; Bowman C; Hu D; Shilatifard A; Shen S; Dynlacht BD
Mol Cell; 2014 Mar; 53(6):979-92. PubMed ID: 24656132
[TBL] [Abstract][Full Text] [Related]
38. Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.
Shinsky SA; Monteith KE; Viggiano S; Cosgrove MS
J Biol Chem; 2015 Mar; 290(10):6361-75. PubMed ID: 25561738
[TBL] [Abstract][Full Text] [Related]
39. The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer.
Lu K; Tao H; Si X; Chen Q
Front Oncol; 2018; 8():502. PubMed ID: 30488017
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
Ding B; Yan L; Zhang Y; Wang Z; Zhang Y; Xia D; Ye Z; Xu H
FEBS Open Bio; 2019 Apr; 9(4):693-706. PubMed ID: 30984543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
